# HBP21 Alleviates Sepsis-Induced Acute Kidney Injury by Targeting PI3K/AKT-Mediated M1 Macrophage Polarization

**Authors:** Na An, Mingzhi Xu, Ruman Chen, Cuijuan Wang, Yafei Bai

PMC · DOI: 10.1155/mi/9021628 · Mediators of Inflammation · 2025-07-27

## TL;DR

HBP21 reduces kidney damage in sepsis by shifting macrophages to an anti-inflammatory state through the PI3K/AKT pathway.

## Contribution

HBP21's novel role in modulating macrophage polarization via PI3K/AKT signaling to treat sepsis-induced kidney injury is demonstrated.

## Key findings

- HBP21 overexpression promotes M2 macrophage polarization and activates PI3K/AKT signaling.
- HBP21 reduces tubular cell apoptosis and improves kidney function in a rat model of sepsis-induced AKI.
- Blocking PI3K/AKT reverses HBP21's protective effects, confirming pathway involvement.

## Abstract

Background: Sepsis-induced acute kidney injury (S-AKI), a life-threatening complication of systemic infection, is driven by macrophage-mediated inflammatory dysregulation. This study explores the role of heat shock binding protein 21 (HBP21) in attenuating renal injury through PI3K/AKT pathway modulation, employing cellular and animal models to dissect its therapeutic mechanisms and clinical relevance.

Methods: In vitro, RAW264.7 cells underwent LPS-induced M1 polarization, and HBP21 expression was manipulated to evaluate its role in macrophage phenotype and PI3K/AKT signaling activation. M1/M2 macrophage polarization was quantified by flow cytometry, while coculture with NRK-52E cells evaluated tubular epithelial cell viability (CCK-8) and apoptosis (flow cytometry). An S-AKI rat model was induced via cecal ligation and puncture (CLP). Renal function (serum creatinine [Scr]/blood urea nitrogen [BUN]), tissue damage (hematoxylin and eosin [H&E]/terminal dUTP nick-end labeling [TUNEL]), and inflammation (Western blot/IHC) were systematically analyzed.

Results: HBP21 overexpression promoted M2 macrophage polarization and activated PI3K/AKT signaling in LPS-stimulated macrophages. Knockdown of HBP21 obtained the opposite data. Inhibition with LY294002 or activation with 740 Y-P reversed these effects, confirming pathway involvement. Cocultured NRK-52E cells exposed to conditioned medium from HBP21-overexpressing macrophages showed a 62.32% increase in viability and a 56.11% reduction in apoptosis under LPS challenge. HBP21 overexpression in vivo lowered Scr (38.5%) and BUN (47.4%), alleviated tubular damage, and shifted renal macrophages toward an M2 anti-inflammatory phenotype with concurrent TNF-α/IL-6 downregulation.

Conclusion: These findings suggest that HBP21 mitigates S-AKI pathogenesis via PI3K/AKT-mediated M2 macrophage polarization, underscoring its translational potential in renal injury therapy.

## Linked entities

- **Genes:** TTC36 (tetratricopeptide repeat domain 36) [NCBI Gene 143941], PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207]
- **Chemicals:** LY294002 (PubChem CID 3973), 740 Y-P (PubChem CID 90488730)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 25125], Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Arg1 (arginase, liver) [NCBI Gene 11846] {aka AI, Arg-1, PGIF}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Cd163 (CD163 molecule) [NCBI Gene 312701] {aka ED2}, Nos2 (nitric oxide synthase 2) [NCBI Gene 24599] {aka Nos2a, iNos}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Casp3 (caspase 3) [NCBI Gene 25402] {aka CPP32-beta, Lice, Yama}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Syt1 (synaptotagmin 1) [NCBI Gene 25716] {aka P65}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Anxa5 (annexin A5) [NCBI Gene 25673] {aka Anx5, CPB-I, LC5}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, Irf3 (interferon regulatory factor 3) [NCBI Gene 292892], Ttc36 (tetratricopeptide repeat domain 36) [NCBI Gene 300676], PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, Hspa1b (heat shock protein family A (Hsp70) member 1B) [NCBI Gene 108348108] {aka HSP70, HSP70-1, HSP70.1, HSP70.2, Hsp70-2, Hsp72}, Bcl2 (BCL2, apoptosis regulator) [NCBI Gene 24224] {aka Bcl-2}, Pik3cb (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta) [NCBI Gene 85243], TTC36 (tetratricopeptide repeat domain 36) [NCBI Gene 143941] {aka HBP21}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Mrc1 (mannose receptor, C type 1) [NCBI Gene 17533] {aka CD206, MR}, Cd86 (CD86 antigen) [NCBI Gene 12524] {aka B7, B7-2, B7.2, B70, CLS1, Cd28l2}, Cd68 (Cd68 molecule) [NCBI Gene 287435], Arg1 (arginase 1) [NCBI Gene 29221], TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** kidney tubular epithelial cell injury (MESH:C567703), S (MESH:D018455), Sepsis (MESH:D018805), proinflammatory cytokines (MESH:D000080424), damage (MESH:D020263), organ damage (MESH:D000092124), kidney damage (MESH:D007674), tissue damage (MESH:D017695), AKI (MESH:D058186), I/R) injury (MESH:D015427), hepatocellular and gastric carcinomas (MESH:D006528), CLP (MESH:D002429), Inflammation (MESH:D007249), tubular (MESH:D000230), ischemic (MESH:D002545), tumor (MESH:D009369), pathological injury (MESH:D005598), multiorgan dysfunction (MESH:D009102), ischemia (MESH:D007511), septic (MESH:D001170), infection (MESH:D007239), renal tubular injury (MESH:D015499), myocardial and hepatic dysfunction (MESH:D008107), cytotoxicity (MESH:D064420)
- **Chemicals:** penicillin (MESH:D010406), AS-IV (MESH:C052064), Lipofectamine 2000 (MESH:C086724), xylene (MESH:D014992), CCK-8 (MESH:D012844), peptide (MESH:D010455), eosin (MESH:D004801), pentobarbital (MESH:D010424), FITC (MESH:D016650), PVDF (MESH:C024865), dUTP (MESH:C027078), paraformaldehyde (MESH:C003043), water (MESH:D014867), oxygen (MESH:D010100), PBS (MESH:D007854), DAPI (MESH:C007293), LY294002 (MESH:C085911), H&amp;E (MESH:D006371), S (MESH:D013455), LPS (MESH:D008070), PI (MESH:D010716), ethanol (MESH:D000431), SDS (MESH:D012967), 740Y-P (-), dehydroandrographolide (MESH:C478098), CO2 (MESH:D002245), buprenorphine (MESH:D002047), DAB (MESH:C000469), paraffin (MESH:D010232), C21 (MESH:C000711730), streptomycin (MESH:D013307), creatinine (MESH:D003404), 3,3'-diaminobenzidine (MESH:D015100), H2O2 (MESH:D006861), hematoxylin (MESH:D006416)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** C0105M
- **Cell lines:** NRK-52E — Rattus norvegicus (Rat), Spontaneously immortalized cell line (CVCL_0468), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), Ov-HBP21 — Mus musculus (Mouse), Finite cell line (CVCL_6F07), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006), CRL-1571 — Homo sapiens (Human), Hypophosphatasia, Finite cell line (CVCL_W031), ATCC TIB-71 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12318628/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12318628/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12318628/full.md

---
Source: https://tomesphere.com/paper/PMC12318628